<aside> 📋

Monoclonal Gammopathies are a group of disorders characterized by the proliferation of a single clone of plasma cells (or occasionally B cells) that produce a monoclonal immunoglobulin, also called M-protein or paraprotein.

</aside>

These conditions range from benign to malignant, with varying potential for progression to multiple myeloma (MM) or related plasma cell dyscrasias.

Pathophysiology

Monoclonal protein (M-protein) is produced by abnormal plasma cells.
May involve intact immunoglobulin (IgG, IgA, rarely IgM, IgD, IgE) or light chains only (κ or λ).
The clone may be non-progressive (as in MGUS) or malignant (as in MM, WM, etc.).

![Genetic alterations involved in the pathogenesis of monoclonal gammopathies. Longitudinal evolution of cPCs according to current knowledge. For the malignant transformation of a post-GC B cell to an MM cell, a genetic event is necessary, initiating the transition to the phase of MGUS. Malignant plasma cell accumulates new genetic mutations over time, acquiring growth advantage in a subclone and leading to further expansion of some clones (orange/red) and to the extinction of others (white, yellow).

Abbreviations: cPCs, clonal plasma cells; post-GC, post-germinal center; MM, multiple myeloma; MGUS, monoclonal gammopathy of undetermined significance.

Plano F, Corsale AM, Gigliotta E, Camarda G, Vullo C, Di Simone M, Shekarkar Azgomi M, Speciale M, Carlisi M, Caccamo N, et al. Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again. Hematology Reports. 2023; 15(1):23-49. https://doi.org/10.3390/hematolrep15010004](attachment:c9e6c200-9486-426f-89a5-afcffd3a0b16:hematolrep-15-00004-g001.png)

Genetic alterations involved in the pathogenesis of monoclonal gammopathies. Longitudinal evolution of cPCs according to current knowledge. For the malignant transformation of a post-GC B cell to an MM cell, a genetic event is necessary, initiating the transition to the phase of MGUS. Malignant plasma cell accumulates new genetic mutations over time, acquiring growth advantage in a subclone and leading to further expansion of some clones (orange/red) and to the extinction of others (white, yellow).

Abbreviations: cPCs, clonal plasma cells; post-GC, post-germinal center; MM, multiple myeloma; MGUS, monoclonal gammopathy of undetermined significance.

Classification

Condition	Features
‣	Asymptomatic; precursor lesion to MM
Smoldering Multiple Myeloma (SMM)	Intermediate stage between MGUS and MM; asymptomatic but higher risk of progression
Multiple Myeloma (MM)	Malignant plasma cell disorder with CRAB symptoms and lytic bone lesions
Waldenström Macroglobulinemia (WM)	IgM-producing lymphoplasmacytic lymphoma; hyperviscosity common
Primary Amyloidosis (AL)	Deposition of light chains as amyloid fibrils in organs
Heavy Chain Disease	Rare; production of incomplete heavy chains without light chains
POEMS syndrome	Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, Skin changes
Solitary plasmacytoma	Localized tumor of monoclonal plasma cells without systemic disease

Diagnosis

Laboratory evaluation:

Test	Diagnostic Utility
Serum Protein Electrophoresis (SPEP)	Detects M-spike in γ-region
Immunofixation electrophoresis (IFE)	Identifies type of immunoglobulin and light chain
Serum Free Light Chain assay	Detects light chain-only disease; κ:λ ratio abnormalities
Urine protein electrophoresis (UPEP)	Detects Bence-Jones proteins (light chains in urine)
Quantitative immunoglobulins	Measure levels of IgG, IgA, IgM

Key diagnostic thresholds:

Disease	M-protein	Bone Marrow Plasma Cells	End-organ Damage (CRAB)
MGUS	<3 g/dL	<10%	None
SMM	≥3 g/dL or FLC ratio abnormal	≥10–60%	None
MM	Any	≥10% or biopsy proven	Present (≥1 CRAB feature or biomarkers)

![Disease progression of monoclonal gammopathy

Kaur J, Sai Sudha Valisekka, Hameed M, et al. Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review. Clinical Lymphoma Myeloma & Leukemia. 2023;23(5):e195-e212. doi:https://doi.org/10.1016/j.clml.2023.02.004](attachment:b8f9fc0b-9f99-461f-b1a7-7d08cbef6180:gr3.jpg)

Disease progression of monoclonal gammopathy

Role of imaging:

Skeletal Survey: Initial screen (low sensitivity)